EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization

Jiaqi Liu iD, Kaikai Wang, Qian Zhu, Yixin Zhang, Yuping Chen, Zhenkun Lou, Jian Yuan

CNS Neuroscience & Therapeutics · 2024-04 · 30 (4)

DOI: 10.1111/cns.14711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 21.04.2024. Verfasst von Jiaqi Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Temozolomide, DNA Repair Enzymes, DNA Modification Methylases, Antineoplastic Agents, Alkylating. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To elucidate the relationship between USP19 and O(6)‐methylguanine‐DNA methyltransferase (MGMT) after temozolomide treatment in glioblastoma (GBM) patients with chemotherapy resistance.

Methods

Screening the deubiquitinase pannel and identifying the deubiquitinase directly interacts with and deubiquitination MGMT. Deubiquitination assay to confirm USP19 deubiquitinates MGMT. The colony formation and tumor growth study in xenograft assess USP19 affects the GBM sensitive to TMZ was performed by T98G, LN18, U251, and U87 cell lines. Immunohistochemistry staining and survival analysis were performed to explore how USP19 is correlated to MGMT in GBM clinical management.

Results

USP19 removes the ubiquitination of MGMT to facilitate the DNA methylation damage repair. Depletion of USP19 results in the glioblastoma cell sensitivity to temozolomide, which can be rescued by overexpressing MGMT. USP19 is overexpressed in glioblastoma patient samples, which positively correlates with the level of MGMT protein and poor prognosis in these patients.

Conclusion

The regulation of MGMT ubiquitination by USP19 plays a critical role in DNA methylation damage repair and GBM patients’ temozolomide chemotherapy response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideDNA Repair EnzymesDNA Modification MethylasesAntineoplastic Agents, AlkylatingDrug Resistance, NeoplasmTumor Suppressor ProteinsDNA MethylationHumansAnimalsCell Line, TumorMice, NudeBrain NeoplasmsGlioblastomaMiceMaleFemaleDacarbazineDNA RepairEndopeptidasesXenograft Model Antitumor AssaysUbiquitination

Stichwörter der Autor:innen

MGMTdeubiquitinationglioblastomatemozolomide resistenceusp19

Substanzen

TemozolomideDNA Repair EnzymesDNA Modification MethylasesAntineoplastic Agents, AlkylatingTumor Suppressor ProteinsMGMT protein, humanDacarbazineEndopeptidases

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • State Key Laboratory of Cardiology and Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

ORCID-Profile: Jiaqi Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, J., Wang, K., Zhu, Q., Zhang, Y., Chen, Y., Lou, Z., & Yuan, J. (2024). USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization. CNS Neuroscience & Therapeutics, 30(4). https://doi.org/10.1111/cns.14711

Vancouver

Liu J, Wang K, Zhu Q, Zhang Y, Chen Y, Lou Z, et al. USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization. CNS Neuroscience & Therapeutics. 2024;30(4). doi:10.1111/cns.14711

BibTeX
@article{Liu2024,
  author = {Liu, Jiaqi and Wang, Kaikai and Zhu, Qian and Zhang, Yixin and Chen, Yuping and Lou, Zhenkun and Yuan, Jian},
  title = {USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {4},
  doi = {10.1111/cns.14711}
}
Kostenlos starten →